148 related articles for article (PubMed ID: 17968978)
1. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Humphries J; Waltham M; Taylor P; Smith A
Br J Surg; 2008 Mar; 95(3):333-7. PubMed ID: 17968978
[TBL] [Abstract][Full Text] [Related]
2. Cysteine protease activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Waltham M; Humphries J; Taylor PR; Smith A
J Vasc Surg; 2007 Dec; 46(6):1260-6. PubMed ID: 18155003
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Wilson WR; Evans J; Bell PR; Thompson MM
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
[TBL] [Abstract][Full Text] [Related]
4. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms (Br J Surg 2008; 95: 333-337).
Fujita T
Br J Surg; 2008 May; 95(5):667; author reply 667-8. PubMed ID: 18386776
[No Abstract] [Full Text] [Related]
5. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
[TBL] [Abstract][Full Text] [Related]
10. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
11. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Kazi M; Zhu C; Roy J; Paulsson-Berne G; Hamsten A; Swedenborg J; Hedin U; Eriksson P
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1341-6. PubMed ID: 15845912
[TBL] [Abstract][Full Text] [Related]
12. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Petersen E; Gineitis A; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):457-61. PubMed ID: 11112465
[TBL] [Abstract][Full Text] [Related]
13. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Evans J; Powell JT; Schwalbe E; Loftus IM; Thompson MM
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):302-3. PubMed ID: 17574455
[TBL] [Abstract][Full Text] [Related]
17. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases.
Abdul-Hussien H; Soekhoe RG; Weber E; von der Thüsen JH; Kleemann R; Mulder A; van Bockel JH; Hanemaaijer R; Lindeman JH
Am J Pathol; 2007 Mar; 170(3):809-17. PubMed ID: 17322367
[TBL] [Abstract][Full Text] [Related]
18. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm.
Gacko M; Chyczewski L; Chrostek L
Pol J Pathol; 1999; 50(2):83-6. PubMed ID: 10481531
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease.
Koole D; Hurks R; Schoneveld A; Vink A; Golledge J; Moran CS; de Kleijn DP; van Herwaarden JA; de Vries JP; Laman JD; Huizinga R; Pasterkamp G; Moll FL
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1497-504. PubMed ID: 22516062
[TBL] [Abstract][Full Text] [Related]
20. Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis.
Franklin IJ; Harley SL; Greenhalgh RM; Powell JT
Br J Surg; 1999 Jun; 86(6):771-5. PubMed ID: 10383577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
